Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs
نویسندگان
چکیده
منابع مشابه
Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.
Ankylosing spondylitis (AS) is a chronic inflammatory disease with a prevalence of 0.1–1.2%, and it normally starts in the third decade of life. In contrast to other inflammatory rheumatic diseases, such as rheumatoid arthritis (RA), the therapeutic options are limited and confined to nonsteroidal antiinflammatory drugs (NSAIDs) and, if this treatment fails, to tumor necrosis factor (TNF) block...
متن کاملNonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment.
Tuberculosis continues to cause 1.4 million deaths annually despite effective treatment being available since the 1970s. The standard 4-drug tuberculosis treatment regimen involving isoniazid, rifampicin, pyrazinamide, and ethambutol achieves 90%cure rates in programmatic settings [1]. Mycobacterium tuberculosis bacilli are difficult to eradicate since they exist in a spectrum of replication st...
متن کاملUse of Nonsteroidal Antiinflammatory Drugs
Clinical trial data have prompted questions about the degree to which patients and their physicians should consider an increased risk of cardiovascular or cerebrovascular events when selecting medications for pain relief. Since the 2005 publication of a Science Advisory on the use of nonsteroidal antiinflammatory drugs (NSAIDs) by the American Heart Association,1 several important events have o...
متن کاملUrolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI)
Background: Increased incidence of renal stone has been reported in ankylosing spondylitis (AS), but unlike some well-known renal involvements, they have not been fully studied. The aim of this study was to investigate the association of AS with urolithiasis and also the relation between urinary stone and severity markers. Methods: One hundred-sixty three AS patients were included in a cross-s...
متن کاملTreatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
Ankylosing spondylitis (AS) is a common (prevalence 0.2-0.9%) chronic inflammatory disease that mainly affects young males and is characterised by inflammatory back pain with sacroiliitis and often arthritis of the peripheral joints. The disease can lead to deformities of the vertebral column, joints and extra-spinal structures, e.g. the eye (uveitis). Non-steroidal anti-inflammatory drugs (NSA...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arthritis & Rheumatism
سال: 2008
ISSN: 0004-3591
DOI: 10.1002/art.23275